Ascending into the future with drug-coated balloons

Sponsored by B. Braun

Anchorperson: R. Jeger
Spokesperson: D. Hildick-Smith
SHOW MORE

Summary

Step into the future of interventional cardiology with comprehensive insights into drug‑coated balloons (DCB). This session covers the new DCB ARC guidelines, previews findings from the impactful BASKET BALL randomised trial, and examines real-world evidence from the SCORE registry. It also addresses the optimisation of acute STEMI care pathways and introduces the innovative crystalline sirolimus-coated balloon, SeQuent Please ASCEND.

Learning Objectives

  • To learn about DCB ARC: a new guideline for setting a standard for DCB PCI
  • To preview the upcoming BASKET BALL randomised controlled trial and understand its potential impact on PCI strategies for complex patients
  • To understand the real-world impact of sirolimus-coated balloons through SCORE registry insights and case study of the crystalline sirolimus DCB
  • To discover how acute STEMI care pathways can be optimised for better outcomes